Verona Pharma PLC American Depositary Share (VRNA) Competitors $105.30 +0.30 (+0.29%) Closing price 04:00 PM EasternExtended Trading$105.17 -0.13 (-0.12%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VRNA vs. ARGX, ONC, BNTX, SMMT, INSM, TEVA, GMAB, RDY, MRNA, and QGENShould you be buying Verona Pharma PLC American Depositary Share stock or one of its competitors? The main competitors of Verona Pharma PLC American Depositary Share include argenex (ARGX), BeOne Medicines (ONC), BioNTech (BNTX), Summit Therapeutics (SMMT), Insmed (INSM), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), and Qiagen (QGEN). These companies are all part of the "pharmaceutical products" industry. Verona Pharma PLC American Depositary Share vs. Its Competitors argenex BeOne Medicines BioNTech Summit Therapeutics Insmed Teva Pharmaceutical Industries Genmab A/S Dr. Reddy's Laboratories Moderna Qiagen argenex (NASDAQ:ARGX) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Does the media prefer ARGX or VRNA? In the previous week, argenex had 11 more articles in the media than Verona Pharma PLC American Depositary Share. MarketBeat recorded 21 mentions for argenex and 10 mentions for Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.75 beat argenex's score of 0.38 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment argenex 5 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Verona Pharma PLC American Depositary Share 9 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is ARGX or VRNA more profitable? argenex has a net margin of 40.20% compared to Verona Pharma PLC American Depositary Share's net margin of 0.00%. argenex's return on equity of 16.15% beat Verona Pharma PLC American Depositary Share's return on equity.Company Net Margins Return on Equity Return on Assets argenex40.20% 16.15% 14.33% Verona Pharma PLC American Depositary Share N/A -69.65%-28.00% Which has preferable valuation and earnings, ARGX or VRNA? argenex has higher revenue and earnings than Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share is trading at a lower price-to-earnings ratio than argenex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioargenex$2.25B16.09$833.04M$16.2136.52Verona Pharma PLC American Depositary Share$42.28M212.02-$173.42M-$2.00-52.65 Do analysts recommend ARGX or VRNA? argenex presently has a consensus price target of $728.06, indicating a potential upside of 22.99%. Verona Pharma PLC American Depositary Share has a consensus price target of $109.00, indicating a potential upside of 3.51%. Given argenex's stronger consensus rating and higher possible upside, research analysts plainly believe argenex is more favorable than Verona Pharma PLC American Depositary Share.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score argenex 0 Sell rating(s) 0 Hold rating(s) 19 Buy rating(s) 2 Strong Buy rating(s) 3.10Verona Pharma PLC American Depositary Share 0 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.15 Which has more volatility and risk, ARGX or VRNA? argenex has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.24, suggesting that its share price is 76% less volatile than the S&P 500. Do institutionals and insiders believe in ARGX or VRNA? 60.3% of argenex shares are owned by institutional investors. Comparatively, 85.9% of Verona Pharma PLC American Depositary Share shares are owned by institutional investors. 2.4% of argenex shares are owned by insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Summaryargenex beats Verona Pharma PLC American Depositary Share on 13 of the 17 factors compared between the two stocks. Get Verona Pharma PLC American Depositary Share News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRNA vs. The Competition Export to ExcelMetricVerona Pharma PLC American Depositary ShareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.94B$3.07B$5.70B$9.51BDividend YieldN/A2.36%4.69%4.01%P/E Ratio-52.6521.0428.0720.05Price / Sales212.02284.46448.5799.42Price / CashN/A42.7636.2258.56Price / Book41.138.378.665.87Net Income-$173.42M-$55.19M$3.25B$258.55M7 Day Performance0.38%5.89%4.20%2.23%1 Month Performance10.71%17.63%10.82%12.76%1 Year Performance375.40%5.09%34.70%19.36% Verona Pharma PLC American Depositary Share Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRNAVerona Pharma PLC American Depositary Share2.6637 of 5 stars$105.30+0.3%$109.00+3.5%+398.3%$8.94B$42.28M-52.6530Positive NewsARGXargenex3.6805 of 5 stars$566.14+0.3%$728.06+28.6%+27.4%$34.65B$2.25B34.931,599Trending NewsUpcoming EarningsAnalyst RevisionONCBeOne Medicines1.2886 of 5 stars$291.93-0.9%$327.56+12.2%N/A$32.00B$3.81B-78.4811,000Insider TradeGap DownBNTXBioNTech1.4075 of 5 stars$108.91-1.0%$136.58+25.4%+37.8%$26.18B$2.98B-32.036,772News CoverageSMMTSummit Therapeutics2.1516 of 5 stars$26.34+0.5%$34.67+31.6%+176.3%$19.56B$700K-77.47110Positive NewsINSMInsmed3.9532 of 5 stars$102.78+0.2%$108.47+5.5%+39.1%$19.50B$363.71M-17.271,271Positive NewsAnalyst ForecastInsider TradeTEVATeva Pharmaceutical Industries4.4316 of 5 stars$16.30+1.5%$24.71+51.7%-0.8%$18.69B$16.54B-14.1736,830Upcoming EarningsGMABGenmab A/S4.0706 of 5 stars$21.70-0.8%$37.80+74.2%-15.2%$13.92B$3.12B12.332,682Positive NewsRDYDr. Reddy's Laboratories2.3286 of 5 stars$14.57+0.6%$16.95+16.4%-8.1%$12.16B$3.81B22.0727,811Earnings ReportMRNAModerna4.2501 of 5 stars$30.97-0.9%$46.61+50.5%-71.2%$11.98B$3.24B-3.555,800Upcoming EarningsAnalyst ForecastQGENQiagen3.7097 of 5 stars$48.06-0.6%$49.40+2.8%+25.6%$10.68B$1.98B120.495,765Positive NewsAnalyst Revision Related Companies and Tools Related Companies ARGX Alternatives ONC Alternatives BNTX Alternatives SMMT Alternatives INSM Alternatives TEVA Alternatives GMAB Alternatives RDY Alternatives MRNA Alternatives QGEN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRNA) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma PLC American Depositary Share Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma PLC American Depositary Share With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRNA Stock Alerts